Skip to main content

Before you Buy: Check the Credit Tab to Make Sure Your Jurisdiction is Accredited!

Back to Search

On Demand

International Emerging Markets - Regulation at the Jurisdictional Level

Average Rating:
Not yet rated
CLI2022 On-Demand
Emerging Markets |  International Law |  International Webinar
Jason Moscovici |  Marie Sanchez |  Dr. Jayashree Mitra |  Daniel Haymann, MBA
1 Hour 06 Minutes
Audio and Video
Access for 6 month(s) after purchase.


“What” a global cannabis industry will look like has been subject to as much speculation as the question of “when”. The famous “3 to 5 year” predictor has become the standard answer to any question touching the timing of a new international market. While jurisdictions such as Canada have given us a glimpse into some of the legal issues faced by a country choosing to legalize federally, other models have since emerged. What are these new jurisdictions? What do they have in common? What legal issues are they facing? Join us for a showcase of other countries who have recently “emerged” to join the global adult use, therapeutic, and industrial hemp markets.



This program is eligible for 1 hours of General CLE credit in 60-minute states, and 1.2 hours of General CLE credit in 50-minute states. Credit hours are estimated and are subject to each state’s approval and credit rounding rules. 

INCBA webinars are generally eligible for credit in the following states: AR, AL, CA, CO, GA, HI, IL, NJ, NM, NY, ND, PA, TX, VT. Additional states may be available for credit upon self-application by attendees. States typically decide whether a program qualifies for MCLE credit in their jurisdiction 4-8 weeks after the program application is submitted. For many live events, credit approval is not received prior to the program.

The on-demand version of this webinar is eligible for credit in the following states: AR, AL, CA, CO, GA, HI, IL, NJ, NM, NY, ND, PA, TX, VT. Additional states may be available for credit upon self-application by attendees.

(Default credit disclaimer updated 02.08.2024)

For current accreditation status, please select your jurisdiction below.



Jason Moscovici's Profile

Jason Moscovici Related Seminars and Products

Partner, Lawyer, Biochemist

Robic, LLP

Jason Moscovici is a partner, lawyer and biochemist with ROBIC, LLP, a multidisciplinary intellectual property law firm from Quebec, Canada. His IP practice specializes in regulated industries such as food, alcohol, cannabis, pharmaceuticals, medical devices, cosmetics, natural health products, advertising and consumer products.

Jason’s focus on the valorization and enforcement of intellectual property, as well as the numerous compliance issues that orbit regulated industries, have allowed him to quickly become one of the most trusted legal advisors to the emerging cannabis industry. His perspectives on compliance, intellectual property and the commercial hurdles related specifically to cannabis are routinely solicited by stakeholders in this space.

Jason leads ROBIC`s cannabis group and sits on the life sciences committee of the firm.

Marie Sanchez's Profile

Marie Sanchez Related Seminars and Products

Lawyer & Founder

Nooa Avocats

Marie Sanchez is a lawyer at the Bars of Paris and Quebec. After beginning her career in Singapore with a large pharmaceutical group, she worked for nearly 10 years in renowned international law firms before founding NOOA Avocats.

A specialist in regulatory and contractual aspects related to life sciences, she has also developed expertise in the field of therapeutic cannabis and well-being hemp. She regularly intervenes in the context of training courses as well as in conferences, in France and abroad.

She holds a Master II Professional in Health Industry Law from the University of Montpellier I as well as an ESSEC-Mannheim Executive MBA.

Dr. Jayashree Mitra's Profile

Dr. Jayashree Mitra Related Seminars and Products


Carlton Fields, P.A.

Dr. Jayashree Mitra focuses on patent litigation, including Hatch-Waxman patent litigation. She represents clients in federal court and before the Patent Trial and Appeal Board and the International Trade Commission in a full range of patent litigation, including Hatch-Waxman actions, inter partes review, post-grant review proceedings, and trade secret disputes. She also advises clients in the cannabis industry and psychedelic industry on regulatory compliance, helping them align their IP strategies to comply with FDA and DEA regulations and guidance.

Jayashree is well known for her detailed understanding of the pharmaceutical, biotechnology, cannabis, psychedelics, and emerging technology sectors. A former neuropharmaceutical researcher at Yale University, Jayashree's technical knowledge extends to small molecules, protein therapeutics, protein conjugates, vaccines, injectables, biologics, and biosimilars, as well as blockchain and data privacy. She has particular insight into the science underlying innovative cannabis technology products and psychedelics. Her research in neuropharmacology at Yale specifically involved analyzing the effects of psychoactive substances on the developing brain.

She also has experience handling antitrust matters, as well as intellectual property due diligence and technology agreements for mergers, acquisitions, and other corporate transactions. She is recognized as a certified information privacy professional (CIPP/US) by the International Association of Privacy Professionals.

Jayashree engages in extensive pro bono work, including criminal appeals and death penalty cases.

Daniel Haymann, MBA's Profile

Daniel Haymann, MBA Related Seminars and Products

Legal Counsel

MME Legal | Tax | Compliance

Daniel Haymann specializes in corporate and commercial law. Based on his extensive business experience, he has a good feel for new markets and understands the requirements of go-to-market and scale-up strategies. As an interdisciplinary and hands-on advisor, his focus is on investments, venture capital and financing transactions as well as regulatory issues in the healthcare and consumer goods sectors.

He advises investors, start-ups and vertically integrated companies along the value chain, including on regulatory issues relating to THC, CBD and other cannabinoids and psychoactive substances, GMP and GDP standards, food and cosmetics regulations and approval procedures before Swissmedic, the Swiss remedy institute.

Daniel is co-founder and co-chair of the European branch of the International Cannabis Bar Association (INCBA Europe). As a Swiss-Israeli dual citizen, he also focuses on serving clients with connections to Israel and strengthening the relevant business relationships.

Prior to his career as a lawyer, Daniel spent over 10 years in senior positions as a commodity trader for multinational corporations.